> Scientific Publications

1. Hardy B, Yampolski I, Kovjazin R, Galli M, Novogrodsky A. A monoclonal antibody against a human B lymphoblastoid cell line induces tumor regression in mice. Cancer Res 1994;54(22):5793–6. PMID 7954401

2. Hardy B, Indjiia L, Rodionov G, Raiter A, Inbal A. Treatment with BAT monoclonal antibody decreases tumor burden in a murine model of leukemia/lymphoma. Int J Oncol 2001;19:897–902. PMID 11604985

3. Hardy B, Kovjazin R, Raiter A, Ganor N, Novogrodsky A. A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice. Proc Natl Acad Sci USA 1997);94(11):5756–60. PMID 9159146

4. Quaglino E, Mastini C, Iezzi M, Forni G, Musiani P, Klapper LN, et al. The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. Vaccine 2005;23:3280–7. PMID 15837233

5. Hardy B, Galli M, Rivlin E, Goren L, Novogrodsky A. Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding protein. Cancer Immunol Immunother
1995;40(6):376–82. PMID 7627994

6. Hardy B, Morgenstern S, Raiter A, Rodionov G, Fadaeev L, Niv Y. BAT monoclonal antibody immunotherapy of human metastatic colorectal carcinoma in mice. Cancer Lett 2005;229(2):217–22. PMID 9289394

7. Hardy B, Kovjazin R, Raiter A, Ganor N, Novogrodsky A. Immune stimulatory and anti-tumor properties of anti-CD3 and BAT monoclonal antibodies: a comparative study. Hum Antibodies 1997;8(2):95–8. PMID 9289394

8. Feinmesser M, Raiter A, Hardy B. Prevention of melanoma metastases in lungs of BAT treated and peptide immunized mice. Int J Oncol 2006;29(4):911–7. PMID 16964387

9. Raiter A, Novogdosky A, Hardy B. Activation of lymphocytes by BAT and anti CTLA-4: comparison of binding to T and B cells. Immunol Lett
1999;69(2):247–51. PMID 10482359

10. Raiter A, Rodionov G, Novogrodsky A, Hardy B. CD4+ T lymphocytes as a primary cellular target for BAT mAb stimulation. Int Immunol
2000;12(11):1623–8. PMID 11058582

11. Hardy B, Raiter A, Rubin M, Sprecher E, Sella A, Flex D, et al. Cancer disease predictive diagnosis:BAT/CD3-positive lymphocytes in cancer patients. Int J Oncol 2005;26(4):971–5. PMID 15753991

12.   Berger R, Rotem-Yehudar R, Slama G, Landes S, Kneller A, Leiba M, Koren-Michowitz M, Shimoni A, and Nagler A. Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin. Cancer Res. 2008; 14(10): 3044-3051. PMID: 18483370